330EGP
- Active ingredient
- insulin aspart+insulin aspart protamine
- Strength
- 100i.u./ml
- Form
- pen
- Manufacturer
- novo nordisk > united company for trading & distribution
- Route
- injection
Uses
Premixed insulin preparation used to improve glycemic control in patients with diabetes mellitus.
Do not use if
Hypoglycemia and hypersensitivity to insulin aspart or any component of the formulation.
Side effects
Common adverse effects include hypoglycemia, injection-site reactions, weight gain, and hypokalemia.
Warnings
Monitor blood glucose regularly and avoid medication errors between insulin products.
How it works
Combines rapid-acting insulin aspart with intermediate-acting insulin aspart protamine for mealtime and basal glucose control.
Storage
Store refrigerated before use and according to manufacturer instructions after opening.